Matches in SemOpenAlex for { <https://semopenalex.org/work/W2066772013> ?p ?o ?g. }
- W2066772013 endingPage "5711" @default.
- W2066772013 startingPage "5700" @default.
- W2066772013 abstract "Our earlier studies identified a fraction (F2) of Leishmania donovani soluble promastigote antigen belonging to 97.4-68 kDa for its ability to stimulate Th1-type cellular responses in cured visceral leishmaniasis (VL) patients as well as in cured hamsters. A further fractionation of F2-fraction into seven subfractions (F2.1-F2.7) and re-assessment for their immunostimulatory responses revealed that out of these, only four (F2.4-F2.7) belonging to 89.9-97.1 kDa, stimulated remarkable Th1-type cellular responses either individually or in a pooled form (P4-7). In this study these potential subfractions were further assessed for their prophylactic potential in combination with BCG against L. donovani challenge in hamsters. Optimum parasite inhibition ( approximately 99%) was obtained in hamsters vaccinated with pooled subfractions and they survived for 1 year. The protection was further supported by remarkable lymphoproliferative, IFN-gamma and IL-12 responses along with profound delayed type hypersensitivity and increased levels of Leishmania-specific IgG2 antibody as observed on days 45, 90 and 120 post-challenge suggesting that a successful subunit vaccine against VL may require multiple Th1-immunostimulatory proteins. MALDI-TOF-MS/MS analysis of these subfractions further revealed that of the 19 identified immunostimulatory proteins, Elongation factor-2, p45, Heat shock protein-70/83, Aldolase, Enolase, Triosephosphate isomerase, Disulfideisomerase and Calreticulin were the major ones in these subfractions." @default.
- W2066772013 created "2016-06-24" @default.
- W2066772013 creator A5004270314 @default.
- W2066772013 creator A5005116678 @default.
- W2066772013 creator A5015032199 @default.
- W2066772013 creator A5026679953 @default.
- W2066772013 creator A5035091733 @default.
- W2066772013 creator A5076603228 @default.
- W2066772013 creator A5089616570 @default.
- W2066772013 date "2008-10-01" @default.
- W2066772013 modified "2023-10-14" @default.
- W2066772013 title "Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1kDa offers long-lasting protection against experimental visceral leishmaniasis" @default.
- W2066772013 cites W1481358372 @default.
- W2066772013 cites W1490664191 @default.
- W2066772013 cites W1503226665 @default.
- W2066772013 cites W1540820582 @default.
- W2066772013 cites W1552315819 @default.
- W2066772013 cites W1559734595 @default.
- W2066772013 cites W1675680196 @default.
- W2066772013 cites W1775749144 @default.
- W2066772013 cites W1818644566 @default.
- W2066772013 cites W1935968257 @default.
- W2066772013 cites W1965832872 @default.
- W2066772013 cites W1966362727 @default.
- W2066772013 cites W1968253395 @default.
- W2066772013 cites W1968790303 @default.
- W2066772013 cites W1974485086 @default.
- W2066772013 cites W1974652725 @default.
- W2066772013 cites W1977007393 @default.
- W2066772013 cites W1979492674 @default.
- W2066772013 cites W1981343187 @default.
- W2066772013 cites W1981970549 @default.
- W2066772013 cites W1982835519 @default.
- W2066772013 cites W1990814691 @default.
- W2066772013 cites W1996039758 @default.
- W2066772013 cites W2006986579 @default.
- W2066772013 cites W2016180501 @default.
- W2066772013 cites W2017177195 @default.
- W2066772013 cites W2019255983 @default.
- W2066772013 cites W2019695577 @default.
- W2066772013 cites W2020079503 @default.
- W2066772013 cites W2021381209 @default.
- W2066772013 cites W2021712302 @default.
- W2066772013 cites W2036341050 @default.
- W2066772013 cites W2037009713 @default.
- W2066772013 cites W2041848338 @default.
- W2066772013 cites W2051703773 @default.
- W2066772013 cites W2052903216 @default.
- W2066772013 cites W2055545800 @default.
- W2066772013 cites W2056620983 @default.
- W2066772013 cites W2061038012 @default.
- W2066772013 cites W2066954635 @default.
- W2066772013 cites W2075501306 @default.
- W2066772013 cites W2077325365 @default.
- W2066772013 cites W2078594804 @default.
- W2066772013 cites W2083670895 @default.
- W2066772013 cites W2085864574 @default.
- W2066772013 cites W2086967479 @default.
- W2066772013 cites W2087811976 @default.
- W2066772013 cites W2096963756 @default.
- W2066772013 cites W2097973390 @default.
- W2066772013 cites W2099340618 @default.
- W2066772013 cites W2100036661 @default.
- W2066772013 cites W2100837269 @default.
- W2066772013 cites W2101939093 @default.
- W2066772013 cites W2105137500 @default.
- W2066772013 cites W2107468208 @default.
- W2066772013 cites W2108658278 @default.
- W2066772013 cites W2111521025 @default.
- W2066772013 cites W2114312842 @default.
- W2066772013 cites W2117451755 @default.
- W2066772013 cites W2123248121 @default.
- W2066772013 cites W2123825848 @default.
- W2066772013 cites W2125874235 @default.
- W2066772013 cites W2127318188 @default.
- W2066772013 cites W2128174530 @default.
- W2066772013 cites W2140056038 @default.
- W2066772013 cites W2141360780 @default.
- W2066772013 cites W2141696784 @default.
- W2066772013 cites W2144159797 @default.
- W2066772013 cites W2148221436 @default.
- W2066772013 cites W2148610656 @default.
- W2066772013 cites W2149200346 @default.
- W2066772013 cites W2155527742 @default.
- W2066772013 cites W2159464509 @default.
- W2066772013 cites W2159975458 @default.
- W2066772013 cites W2160971502 @default.
- W2066772013 cites W2161082674 @default.
- W2066772013 cites W2163510491 @default.
- W2066772013 cites W2172199089 @default.
- W2066772013 doi "https://doi.org/10.1016/j.vaccine.2008.08.021" @default.
- W2066772013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18762224" @default.
- W2066772013 hasPublicationYear "2008" @default.
- W2066772013 type Work @default.
- W2066772013 sameAs 2066772013 @default.
- W2066772013 citedByCount "46" @default.
- W2066772013 countsByYear W20667720132012 @default.
- W2066772013 countsByYear W20667720132013 @default.